US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

Watchlist
  • 0.384
  • +0.009+2.43%
15min DelayClose May 28 16:00 ET
2.63MMarket Cap-738P/E (TTM)

Agile Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-55.24%-2.48M
73.36%-9.58M
111.03%172K
102.19%365K
-190.35%-8.52M
89.19%-1.6M
44.87%-35.95M
90.62%-1.56M
10.10%-16.7M
80.87%-2.93M
Net income from continuing operations
123.82%1.28M
43.08%-14.47M
-13.71%-4.47M
86.54%-798K
26.34%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.66%-5.93M
70.70%-5.17M
Operating gains losses
-149.14%-4.2M
53.05%-6.76M
103.88%130K
-35.00%-3.53M
76.26%-1.67M
-21.89%-1.69M
-276.22%-14.4M
---3.35M
---2.61M
---7.05M
Depreciation and amortization
10.75%103K
-74.84%386K
9.89%100K
-62.60%98K
-83.98%95K
-84.18%93K
-30.99%1.53M
-84.17%91K
-52.54%262K
7.82%593K
Other non cash items
-56.03%135K
-46.01%1.06M
-32.63%225K
-69.93%252K
-26.19%279K
-26.73%307K
18.54%1.97M
-16.29%334K
110.55%838K
-11.48%378K
Change In working capital
-102.79%-128K
393.16%7.42M
-35.47%2.82M
139.84%3.9M
-150.92%-3.89M
196.44%4.58M
11.32%-2.53M
341.47%4.38M
-93.62%-9.8M
1,489.40%7.65M
-Change in receivables
-659.45%-1.42M
99.19%-15K
-61.38%129K
157.88%940K
-131.46%-1.34M
105.28%254K
-176.05%-1.84M
249.11%334K
-1,043.66%-1.62M
603.31%4.25M
-Change in inventory
-14.90%-1.01M
-189.25%-2.21M
-1,758.82%-1.13M
-76.98%125K
-192.07%-325K
49.10%-879K
87.87%-763K
104.81%68K
138.43%543K
118.86%353K
-Change in prepaid assets
-87.69%32K
157.95%2.27M
-108.64%-210K
121.54%607K
188.04%1.61M
-63.22%260K
191.00%880K
3,064.63%2.43M
-96.10%-2.82M
327.48%560K
-Change in payables and accrued expense
-53.08%2.36M
1,324.20%7.69M
159.68%4.12M
139.48%2.31M
-247.80%-3.77M
359.00%5.03M
-112.07%-628K
-42.15%1.59M
-188.19%-5.86M
-17.83%2.55M
-Change in other current liabilities
-12.99%-87K
-82.29%-319K
-95.35%-84K
-92.86%-81K
-11.59%-77K
-266.67%-77K
-33.59%-175K
-48.28%-43K
-16.67%-42K
-102.94%-69K
Cash from discontinued investing activities
Operating cash flow
-55.24%-2.48M
73.36%-9.58M
111.03%172K
102.19%365K
-190.35%-8.52M
89.19%-1.6M
44.87%-35.95M
90.62%-1.56M
10.10%-16.7M
80.87%-2.93M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
0
-100.34%-133K
0
0
-100.04%-7K
Net PPE purchase and sale
--0
--0
--0
--0
--0
--0
50.56%-133K
--0
--0
91.03%-7K
Net investment purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
-100.34%-133K
--0
--0
-100.04%-7K
Financing cash flow
Cash flow from continuing financing activities
225.84%2.54M
-68.95%6.89M
-173.79%-487K
-102.83%-278K
-43.76%6.88M
248.76%778K
-27.08%22.18M
-96.87%660K
334.17%9.82M
85.37%12.23M
Net issuance payments of debt
-718.22%-1.84M
92.25%-1.35M
-116.89%-488K
97.14%-348K
---286K
95.50%-225K
---17.38M
---225K
---12.15M
--0
Net common stock issuance
--0
-76.76%8.24M
-99.89%1K
-99.68%70K
-41.42%7.16M
188.22%1M
16.75%35.43M
-95.80%886K
871.31%21.97M
85.37%12.23M
Net preferred stock issuance
----
--0
--0
--0
----
----
--4.13M
---1K
--0
--0
Proceeds from stock option exercised by employees
--4.38M
--0
----
----
----
----
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
225.84%2.54M
-68.95%6.89M
-173.79%-487K
-102.83%-278K
-43.76%6.88M
248.76%778K
-27.08%22.18M
-96.87%660K
334.17%9.82M
85.37%12.23M
Net cash flow
Beginning cash position
-51.28%2.56M
-72.60%5.25M
-53.25%2.87M
-78.62%2.79M
18.33%4.43M
-72.60%5.25M
32.36%19.14M
-58.30%6.15M
-50.12%13.03M
-77.27%3.74M
Current changes in cash
107.22%59K
80.65%-2.69M
64.85%-316K
101.28%88K
-117.71%-1.64M
94.69%-817K
-396.94%-13.9M
-120.39%-899K
39.54%-6.88M
-3.83%9.28M
End cash Position
-40.96%2.62M
-51.26%2.56M
-51.26%2.56M
-53.25%2.87M
-78.62%2.79M
18.33%4.43M
-72.60%5.25M
-72.60%5.25M
-58.30%6.15M
-50.12%13.03M
Free cash flow
-55.24%-2.48M
73.46%-9.58M
111.03%172K
102.19%365K
-189.66%-8.52M
89.28%-1.6M
44.89%-36.08M
90.65%-1.56M
10.42%-16.7M
80.92%-2.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -55.24%-2.48M73.36%-9.58M111.03%172K102.19%365K-190.35%-8.52M89.19%-1.6M44.87%-35.95M90.62%-1.56M10.10%-16.7M80.87%-2.93M
Net income from continuing operations 123.82%1.28M43.08%-14.47M-13.71%-4.47M86.54%-798K26.34%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.66%-5.93M70.70%-5.17M
Operating gains losses -149.14%-4.2M53.05%-6.76M103.88%130K-35.00%-3.53M76.26%-1.67M-21.89%-1.69M-276.22%-14.4M---3.35M---2.61M---7.05M
Depreciation and amortization 10.75%103K-74.84%386K9.89%100K-62.60%98K-83.98%95K-84.18%93K-30.99%1.53M-84.17%91K-52.54%262K7.82%593K
Other non cash items -56.03%135K-46.01%1.06M-32.63%225K-69.93%252K-26.19%279K-26.73%307K18.54%1.97M-16.29%334K110.55%838K-11.48%378K
Change In working capital -102.79%-128K393.16%7.42M-35.47%2.82M139.84%3.9M-150.92%-3.89M196.44%4.58M11.32%-2.53M341.47%4.38M-93.62%-9.8M1,489.40%7.65M
-Change in receivables -659.45%-1.42M99.19%-15K-61.38%129K157.88%940K-131.46%-1.34M105.28%254K-176.05%-1.84M249.11%334K-1,043.66%-1.62M603.31%4.25M
-Change in inventory -14.90%-1.01M-189.25%-2.21M-1,758.82%-1.13M-76.98%125K-192.07%-325K49.10%-879K87.87%-763K104.81%68K138.43%543K118.86%353K
-Change in prepaid assets -87.69%32K157.95%2.27M-108.64%-210K121.54%607K188.04%1.61M-63.22%260K191.00%880K3,064.63%2.43M-96.10%-2.82M327.48%560K
-Change in payables and accrued expense -53.08%2.36M1,324.20%7.69M159.68%4.12M139.48%2.31M-247.80%-3.77M359.00%5.03M-112.07%-628K-42.15%1.59M-188.19%-5.86M-17.83%2.55M
-Change in other current liabilities -12.99%-87K-82.29%-319K-95.35%-84K-92.86%-81K-11.59%-77K-266.67%-77K-33.59%-175K-48.28%-43K-16.67%-42K-102.94%-69K
Cash from discontinued investing activities
Operating cash flow -55.24%-2.48M73.36%-9.58M111.03%172K102.19%365K-190.35%-8.52M89.19%-1.6M44.87%-35.95M90.62%-1.56M10.10%-16.7M80.87%-2.93M
Investing cash flow
Cash flow from continuing investing activities 000000-100.34%-133K00-100.04%-7K
Net PPE purchase and sale --0--0--0--0--0--050.56%-133K--0--091.03%-7K
Net investment purchase and sale ------0------------------0------------
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0-100.34%-133K--0--0-100.04%-7K
Financing cash flow
Cash flow from continuing financing activities 225.84%2.54M-68.95%6.89M-173.79%-487K-102.83%-278K-43.76%6.88M248.76%778K-27.08%22.18M-96.87%660K334.17%9.82M85.37%12.23M
Net issuance payments of debt -718.22%-1.84M92.25%-1.35M-116.89%-488K97.14%-348K---286K95.50%-225K---17.38M---225K---12.15M--0
Net common stock issuance --0-76.76%8.24M-99.89%1K-99.68%70K-41.42%7.16M188.22%1M16.75%35.43M-95.80%886K871.31%21.97M85.37%12.23M
Net preferred stock issuance ------0--0--0----------4.13M---1K--0--0
Proceeds from stock option exercised by employees --4.38M--0------------------0------------
Cash from discontinued financing activities
Financing cash flow 225.84%2.54M-68.95%6.89M-173.79%-487K-102.83%-278K-43.76%6.88M248.76%778K-27.08%22.18M-96.87%660K334.17%9.82M85.37%12.23M
Net cash flow
Beginning cash position -51.28%2.56M-72.60%5.25M-53.25%2.87M-78.62%2.79M18.33%4.43M-72.60%5.25M32.36%19.14M-58.30%6.15M-50.12%13.03M-77.27%3.74M
Current changes in cash 107.22%59K80.65%-2.69M64.85%-316K101.28%88K-117.71%-1.64M94.69%-817K-396.94%-13.9M-120.39%-899K39.54%-6.88M-3.83%9.28M
End cash Position -40.96%2.62M-51.26%2.56M-51.26%2.56M-53.25%2.87M-78.62%2.79M18.33%4.43M-72.60%5.25M-72.60%5.25M-58.30%6.15M-50.12%13.03M
Free cash flow -55.24%-2.48M73.46%-9.58M111.03%172K102.19%365K-189.66%-8.52M89.28%-1.6M44.89%-36.08M90.65%-1.56M10.42%-16.7M80.92%-2.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg